Britain has become the first country in the world to approve a potentially game-changing Covid-19 antiviral pill jointly developed by the U.S -based Merch and Ridgeback Biotherapeutics, in a boost to the fight against the pandemic.
WHO Director-General Tedros Ghebreyesus and UN Geneva Office Director-General Tatiana Valovaya were honoured with the Nizami Ganjavi International Award.
Bharat Biotech's Covaxin has been approved by the WHO, with the technical advisory team recommending the India-made vaccine for emergency use in anyone aged 18 and up.